Earnings Ahead

EXEL - Exelixis, Inc.

19.37 0.17 0.89

Exelixis, Inc.

Exelixis, Inc.

About

Profile

Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following earl


Headquarters

Alameda, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

EXEL



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Exelixis Non-GAAP EPS of $0.10 misses by $0.09, revenue of $471.92M misses by $1.47M
  • Exelixis Q3 2023 Earnings Preview
  • Exelixis gains as Cabometyx patent trial ends (update)
  • Exelixis slumps amid Cabometyx patent trial (update)
  • Exelixis reports positive results for Cabometyx in treating neuroendocrine tumors
  • Exelixis started at buy at Wainwright on targeted oncology pipeline
  • Exelixis inks licensing deal with Insilico for tumor candidate
  • Exelixis reports positive results for Cabometyx in pancreatic cancer type
  • Exelixis appoints Amy Peterson as Chief Medical Officer
  • Exelixis lead product hits main goal in Phase 3 prostate cancer trial
  • Exelixis Non-GAAP EPS of $0.31 beats by $0.09, revenue of $469.85M beats by $25.02M
  • Exelixis Q2 2023 Earnings Preview
  • Exelixis, Teva settle patent dispute over cancer drug Cabometyx
  • Exelixis sees three Farallon nominees elected to board
  • Exelixis a new overweight at Piper Sandler on Cabometyx, pipeline
  • Exelixis Non-GAAP EPS of $0.16 misses by $0.06, revenue of $408.8M misses by $13.86M
  • Exelixis Q1 2023 Earnings Preview
  • Exelixis board member resigns; Farallon gets third board seat in victory
  • Exelixis holder Farallon files definitive materials in proxy battle
  • Exelixis supports two of Farallon's board nominees as it faces proxy fight
Date Price Open High Low Vol Change ER
Oct 9, 2023 21.49 21.99
22.03
21.11
2.3M -3.29%
Oct 6, 2023 22.22 22.05
22.34
22.03
1.7M 0.36%
Oct 5, 2023 22.14 21.76
22.25
21.76
1.6M 1.75%
Oct 4, 2023 21.76 21.85
21.85
21.63
2.8M -0.55%
Oct 3, 2023 21.88 22.19
22.24
21.76
1.4M -1.53%
 
Oct 2, 2023 22.22 21.98
22.32
21.81
2.1M 1.69%
Sep 29, 2023 21.85 22.35
22.42
21.8
2.1M -2.41%
Sep 28, 2023 22.39 22.19
22.51
22.08
3.6M 0.90%
Sep 27, 2023 22.19 21.81
22.19
21.79
2.1M 2.02%
Sep 26, 2023 21.75 21.84
22.12
21.74
1.4M -0.37%
Sep 25, 2023 21.83 21.62
21.99
21.49
1.8M 1.63%
Sep 22, 2023 21.48 21.6
21.75
21.44
2.2M -0.46%
Sep 21, 2023 21.58 21.5
21.8
21.46
2.0M 0.33%
Sep 20, 2023 21.51 21.44
21.63
21.3
1.4M 0.42%
Sep 19, 2023 21.42 21.36
21.55
21.3
1.8M 0.33%
Sep 18, 2023 21.35 21.84
21.9
21.31
3.2M -2.11%
Sep 15, 2023 21.81 22.26
22.27
21.59
6.6M -2.07%
Sep 14, 2023 22.27 22.21
22.4
22.15
1.8M 0.50%
Sep 13, 2023 22.16 22.05
22.27
22.02
1.9M 0.32%
Sep 12, 2023 22.09 22.08
22.23
21.91
1.7M 0.45%
Sep 11, 2023 21.99 22.03
22.18
21.89
1.9M -0.54%
Sep 8, 2023 22.11 22.13
22.23
22.02
1.4M 0.41%
Sep 7, 2023 22.02 22.28
22.36
22.01
1.9M -0.9%
Sep 6, 2023 22.22 22.35
22.35
22.02
1.6M -0.22%
Sep 5, 2023 22.27 22.64
22.74
22.27
2.0M -2.07%
Sep 1, 2023 22.74 22.56
22.8
22.5
1.4M 1.56%
Aug 31, 2023 22.39 22.49
22.57
22.3
1.9M -0.49%
Aug 30, 2023 22.5 22.4
22.64
22.35
2.4M 0.45%
Aug 29, 2023 22.4 22.15
22.44
22.15
2.4M 0.99%
Aug 28, 2023 22.18 21.99
22.3
21.99
2.3M 0.86%
Aug 25, 2023 21.99 21.76
22.11
21.74
2.3M 1.10%
Aug 24, 2023 21.75 22
22.15
21.74
2.1M 0%
Aug 23, 2023 21.75 21.54
21.79
21.54
1.7M 1.26%
Aug 22, 2023 21.48 21.45
21.59
21.38
1.9M 0.51%
Aug 21, 2023 21.37 21.16
21.44
21.05
2.3M 1.28%
Aug 18, 2023 21.1 20.85
21.17
20.84
2.1M 0.48%
Aug 17, 2023 21 21.35
21.42
20.99
1.7M -1.5%
Aug 16, 2023 21.32 21.55
21.63
21.27
1.7M -1.11%
Aug 15, 2023 21.56 21.59
21.61
21.47
1.4M 0.23%
Aug 14, 2023 21.51 21.5
21.75
21.44
2.5M -0.05%
Aug 11, 2023 21.52 21.18
21.59
21.18
2.5M 1.75%
Aug 10, 2023 21.15 20.7
21.17
20.66
2.6M 2.57%
Aug 9, 2023 20.62 20.48
20.82
20.44
2.5M 0.59%
Aug 8, 2023 20.5 20.18
20.57
20.02
4.9M 1.23%
Aug 7, 2023 20.25 20.3
20.47
20.17
1.9M -0.1%
Aug 4, 2023 20.27 20.68
20.7
20.22
3.7M -2.36%
Aug 3, 2023 20.76 20.44
20.78
20.22
2.9M 2.06%
Aug 2, 2023 20.34 20
20.74
19.88
5.0M 3.62%
Aug 1, 2023 19.63 19.74
19.79
19.55
1.9M -0.41%
Jul 31, 2023 19.71 19.84
19.88
19.5
2.4M -0.71%
Jul 28, 2023 19.85 19.66
19.89
19.65
1.8M 1.28%
Jul 27, 2023 19.6 19.87
19.96
19.57
2.2M -1.11%
Jul 26, 2023 19.82 19.76
19.95
19.58
2.0M 0.25%
Jul 25, 2023 19.77 19.79
20
19.71
1.4M -0.6%
Jul 24, 2023 19.89 19.76
20.19
19.76
3.2M 1.02%
Jul 21, 2023 19.69 19.98
20.03
19.68
1.7M -0.91%
Jul 20, 2023 19.87 19.64
19.88
19.63
3.6M 1.69%
Jul 19, 2023 19.54 19.31
19.6
19.31
2.0M 1.24%
Jul 18, 2023 19.3 19.19
19.66
19.16
2.5M 0.57%
Jul 17, 2023 19.19 19.39
19.57
19.18
1.7M 0%